 |
Equilib 3-phase Research Program
The Evince International Research Group is currently in the second phase of a three phase research program. The current study is designed to confirm the hypothesis that
“nutriceutical intervention can be an effective first step in the treatment hierarchy for patients with CNS imbalances”.
Four peer-reviewed open-label and clinical research studies provide initial results supporting this hypothesis. Click on the link below to view the most recent research abstract.
Effective Mood Stabilization With a Chelated Mineral Supplement: An Open-Label Trial in Bipolar Disorder - Bonnie J. Kaplan, Ph.D.(Research psychologist, University of Calgary)*
|
Research Design Summary
The research protocol has been designed to determine the optimum usage level for each CNS condition, determine which CNS conditions can be ameliorated by nutriceutical intervention, determine the effectiveness on each category (A-D) of participant (based on severity of symptoms), and assess all positive and negative long-term side effects – including drug/nutrient interactions where applicable.
We require a significant number of research participants to fully populate the study. Eight CNS conditions and three age categories will be studied. When all cells are fully populated, additional participants will not be added to the program.
|
Benefits to Research Participants
- Nutriceutical intervention is designed to provide the body with the nutritional support needed for homeostasis. It is increasingly recognized that many CNS concerns may be associated with an imbalance in the delicate chemistry of the brain. Nutritional intervention may be able to restore the chemical balance in the brain and provide relief to individuals in the early stages of distress.
- Nutriceutical intervention has few if any uncomfortable or enduring side effects.
- The costs of medication, psychotherapy and other forms of therapy, which can be very high and prolonged, can be dramatically reduced if nutriceutical intervention is effective.
|
The Journal of Clinical Psychiatry
This peer reviewed article, along with with a research commentary, can be read in its entirety by registering at The Journal of Clinical Psychiatry website at www.psychiatrist.com Here are the steps to take to register and read full text content:
Go to www.psychiatrist.com and click on "Join the Net Society" on the left navigation bar.
Complete the registration form and click on "Continue" (a fee is required to have full on-line access).
Once registered, return to the main page at www.psychiatrist.com and choose "Read JCP Online" on the left navigation bar. You will need to re-type www.psychiatrist.com rather than click on "Home Page" to return to the main page, in order to make the registration take effect.
Scroll down the "monthly issues" of this section (entitled, Full Text Access to the Journal of Clinical Psychiatry) until you get to Volume 62, Number 12, December 2001 - click on it.
Click on page 933 to read the commentary on "Do Vitamins or Minerals (Apart From Lithium) Have Mood-Stabilizing Effects?".
Click on page 936 to read Dr. Kaplan's report on "Effective Mood Stabilization With a Chelated Mineral Supplement: An Open-Label Trial in Bipolar Disorder".
|
|
|
|
